October, 2024
October 2024
M T W T F S S
 123456
78910111213
14151617181920
21222324252627
28293031  
Ashish M. Kamat: Deintensification of Treatment for Low-grade Bladder Tumors
Sep 20, 2024, 18:57

Ashish M. Kamat: Deintensification of Treatment for Low-grade Bladder Tumors

Ashish M. Kamat posted on X about recent paper by Roberto Contieri et al., titled “Deintensification of Treatment for Low-grade Bladder Tumors: A Collaborative Review by the International Bladder Cancer Group (IBCG)” published on Science Direct.

Authors: Roberto Contieri, Mark S. Soloway, Paolo Gontero, Harry Herr, Wassim Kassouf, Laura S. Mertens, Marco Moschini, Michael O’Donnell, Joan Palou, Sarah P. Psutka, Morgan Rouprêt, Jeremy Y.C. Teoh, Ashish M. Kamat.

Ashish M. Kamat: Deintensification of Treatment for Low-grade Bladder Tumors

“Deintensification of Treatment for Low-grade Bladder Tumors: A Collaborative Review by the International Bladder Cancer Group (IBCG)”

Source: Ashish M. Kamat/X

Ashish M. Kamat is the Endowed Professor of Urologic Oncology (Surgery) and Cancer Research at University of Texas MD Anderson Cancer Center. He is also President of the International Bladder Cancer Group (IBCG) and International Bladder Cancer Network (IBCN).

He is Associate Editor for European Urology Oncology, Editor for the UroToday Bladder Cancer Center of Excellence, directed the MDACC Urologic Oncology Fellowship from 2005-2016, and is an alumnus of the AUA Leadership Program.